Paradigm Health has appointed Karen E. Knudsen, MBA, PhD, to its Board of Directors as they work on rebuilding the clinical research ecosystem. The company is set to launch its eSource clinical trial data application. This appointment highlights the company's focus on advancing healthcare research. The addition of Dr. Knudsen brings valuable expertise to the organization. The upcoming launch of the eSource application is expected to enhance clinical trial data management.
Representational image
COLUMBUS, Ohio, March 20, 2025 - Paradigm Health, which is rebuilding the clinical research ecosystem, today announced the appointment of Karen E. Knudsen, MBA, PhD, to its Board of Directors, alongside the upcoming launch of its eSource clinical trial data application. Dr. Knudsen is a globally recognized cancer scientist and executive leader who joins Paradigm Health's board following a successful term as Chief Executive Officer of the American Cancer Society (ACS) and its advocacy affiliate, ACS Cancer Action Network. She brings extensive expertise around the challenges and opportunities in clinical research to this Board appointment.
"Having led a National Cancer Institute-designated cancer center and oncology team across a 16-hospital, two-state system, I've witnessed firsthand how administrative burden limits clinical trial capacity," said Dr. Knudsen. "Paradigm Health's technology-driven approach addresses one of healthcare's most persistent challenges: bringing trials to where patients live. Doing so will help expand who has access to trials and improve data so we know that new treatments will work for the populations they're designed to treat. Supporting Paradigm Health aligns with my career-long focus on expanding access to innovative care options."
Dr. Knudsen previously served as EVP of Oncology Services for Jefferson Health and Enterprise Director of the Sidney Kimmel Comprehensive Cancer Center, a National Cancer Institute (NCI)-designated center of excellence. She has served on the NCI Board of Scientific Advisors and as President of the Association of American Cancer Institutes. She has been a professor at Thomas Jefferson University for over seventeen years, now serving as Professor Emerita.
"Karen is one of the most respected voices in oncology research and patient advocacy and a leader in the movement to make clinical trials more economic and efficient," said Kent Thoelke, founder and CEO of Paradigm Health.
Paradigm Health is also announcing the upcoming launch of eSource Casebook, the first application in the Study Conduct solution suite, which automates the end-to-end process of capturing and auditing clinical trial data.
"Seeing eSource Casebook in action was a lightning bolt moment," said Knudsen. "Today's infrastructure forces provider research teams into an exhausting cycle of finding and documenting patient information in their EMR, only to re-enter nearly identical details into trial-specific electronic data capture systems. This redundant, manual process is not only time-consuming but also incredibly resource-draining."
Today there is an eight-day average delay from patient clinical visit to study data entry, a gap driven by overburdened healthcare provider staff and overwhelming levels of manual data entry. Paradigm Health's eSource Casebook solution is an EMR-integrated application that extracts trial-specific data from the EMR (including structured and unstructured data), autopopulates electronic clinical report forms (eCRFs), and seamlessly pushes the information in the appropriate format to the trial sponsor's electronic data capture (EDC) systems.
Organizations interested in the April release of eSource Casebook can learn more by contacting the Paradigm Health team.
Paradigm Health is rebuilding the clinical research ecosystem by creating a platform that enables equitable access to trials for all patients, while enhancing trial efficiency and reducing the barriers to participation for healthcare providers. For more information, please visit the Paradigm Health website. Paradigm Health's platform and services are currently deployed at over 400 research sites across 1,000 healthcare provider locations.
By entering your email you agree to our terms & conditions and privacy policy. You will be getting daily AI news in your inbox at 7 am your time to keep you ahead of the curve. Don't worry you can always unsubscribe.